SBRT Followed by Ipilimumab N01, Sintilimab, Nab-Paclitaxel and Gemcitabine for Locally Advanced Pancreatic Cancer
Clinical trial NCT07683221 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT07683221
- Sponsor
- Shandong Cancer Hospital and Institute
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-15
- Primary completion
- 2029-07-15
- Enrollment
- 47
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.